The Board of Directors of Hau Giang Pharmaceutical Joint Stock Company (DHT) has met and passed a resolution to adjust the implementation schedule for the construction project of the Hataphar pharmaceutical plant. This adjustment aims to meet changes in the development strategy and market demand. DHT stated that the completion timeline of the plant will be expedited to timely commence production, addressing raw material shortages. Additionally, the board confirmed it would strengthen management and oversight of the project to ensure all set objectives are achieved. The Hataphar plant project is considered a significant milestone in enhancing production capacity and expanding the company’s market.
Leave a Reply